Bioptik Technology (4161) — Free Cash Flow Generation Index

Latest as of December 2025: 0.91x

Bioptik Technology (4161) has a Free Cash Flow Generation Index of 0.91x as of December 2025. Free cash flow of NT$48.27 Million represents 1% of operating cash flow (NT$53.21 Million). Explore reinvestment intensity of Bioptik Technology to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.91x
Free Cash Flow / Operating CF

Free Cash Flow

NT$48.27 Million
TWD

Operating Cash Flow

NT$53.21 Million
TWD

Capital Expenditures

NT$4.94 Million
TWD

Bioptik Technology Free Cash Flow Generation Index (2017–2025)

Historical FCF Generation Index trend for Bioptik Technology across 8 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Bioptik Technology.

Annual Free Cash Flow Generation for Bioptik Technology (2017–2025)

Year-by-year Free Cash Flow Generation Index for Bioptik Technology. Check Bioptik Technology (4161) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (TWD) Operating CF Capital Expenditures YoY Change
2025 0.62x NT$37.19 Million NT$59.99 Million NT$22.80 Million ▼ -31.3%
2024 0.90x NT$143.32 Million NT$158.82 Million NT$15.51 Million ▲ +6.3%
2023 0.85x NT$174.91 Million NT$205.95 Million NT$31.04 Million ▲ +23.1%
2022 0.69x NT$37.98 Million NT$55.06 Million NT$17.08 Million ▲ +168.6%
2020 -1.01x NT$-6.61 Million NT$6.57 Million NT$13.18 Million ▼ -429.7%
2019 0.30x NT$12.51 Million NT$41.03 Million NT$27.42 Million ▲ +226.1%
2018 -0.24x NT$-10.11 Million NT$41.83 Million NT$50.96 Million ▲ +94.9%
2017 -4.72x NT$-52.04 Million NT$11.02 Million NT$62.72 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).